Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Advanced Phosphate Binder is a dietary supplement formulated to assist in the management of serum phosphate levels by reducing the absorption of dietary phosphorus. The product's active ingredient is aluminum magnesium silicate, specifically a high-capacity, non-absorbable form known as NeoSorb. Its mechanism of action involves the sequestration of inorganic phosphate ions within the gastrointestinal tract. When taken with meals, the compound binds to phosphate to form an insoluble complex that is not absorbed by the intestinal mucosa and is subsequently excreted in the feces. This action effectively lowers the total amount of phosphate entering the systemic circulation, which is a critical consideration for individuals with compromised renal function or those at risk of hyperphosphatemia. The formulation is designed to be chemically stable across a wide pH range, ensuring consistent binding activity throughout the digestive process while minimizing the systemic absorption of aluminum or magnesium.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Advanced Phosphate Binder.